Brian Joseph Cahill - 02 Feb 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
Chief Financial Officer
Signature
/s/ Brian Cahill
Issuer symbol
EGRX
Transactions as of
02 Feb 2022
Net transactions value
-$36,249
Form type
4
Filing time
04 Feb 2022, 15:58:44 UTC
Previous filing
01 Feb 2022
Next filing
02 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability $36,249 -805 -3.2% $45.03 24,667 02 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.